nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP2C19—prostate cancer	0.182	0.611	CbGaD
Etravirine—CYP3A4—prostate cancer	0.115	0.389	CbGaD
Etravirine—CYP2C19—Bicalutamide—prostate cancer	0.0316	0.069	CbGbCtD
Etravirine—CYP2C19—Nilutamide—prostate cancer	0.0316	0.069	CbGbCtD
Etravirine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0291	0.0635	CbGbCtD
Etravirine—CYP2C9—Bicalutamide—prostate cancer	0.0263	0.0573	CbGbCtD
Etravirine—CYP2C9—Nilutamide—prostate cancer	0.0263	0.0573	CbGbCtD
Etravirine—CYP2C19—Flutamide—prostate cancer	0.0262	0.0572	CbGbCtD
Etravirine—ABCB1—Estramustine—prostate cancer	0.0237	0.0517	CbGbCtD
Etravirine—CYP2C9—Estrone—prostate cancer	0.0157	0.0344	CbGbCtD
Etravirine—ABCB1—Cabazitaxel—prostate cancer	0.0156	0.0341	CbGbCtD
Etravirine—CYP3A4—Bicalutamide—prostate cancer	0.0153	0.0333	CbGbCtD
Etravirine—ABCB1—Estrone—prostate cancer	0.0153	0.0333	CbGbCtD
Etravirine—CYP3A4—Estramustine—prostate cancer	0.0142	0.031	CbGbCtD
Etravirine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0136	0.0297	CbGbCtD
Etravirine—CYP3A4—Flutamide—prostate cancer	0.0127	0.0276	CbGbCtD
Etravirine—CYP3A4—Abiraterone—prostate cancer	0.0127	0.0276	CbGbCtD
Etravirine—CYP2C9—Capecitabine—prostate cancer	0.0119	0.026	CbGbCtD
Etravirine—CYP2C19—Estradiol—prostate cancer	0.0109	0.0237	CbGbCtD
Etravirine—ABCB1—Conjugated Estrogens—prostate cancer	0.00999	0.0218	CbGbCtD
Etravirine—CYP3A4—Cabazitaxel—prostate cancer	0.00936	0.0204	CbGbCtD
Etravirine—CYP2C19—Prednisone—prostate cancer	0.00935	0.0204	CbGbCtD
Etravirine—CYP3A4—Estrone—prostate cancer	0.00915	0.02	CbGbCtD
Etravirine—ABCB1—Mitoxantrone—prostate cancer	0.00908	0.0198	CbGbCtD
Etravirine—CYP2C9—Estradiol—prostate cancer	0.00904	0.0197	CbGbCtD
Etravirine—ABCB1—Estradiol—prostate cancer	0.00877	0.0191	CbGbCtD
Etravirine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00815	0.0178	CbGbCtD
Etravirine—ABCB1—Prednisone—prostate cancer	0.00754	0.0165	CbGbCtD
Etravirine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00598	0.0131	CbGbCtD
Etravirine—ABCB1—Etoposide—prostate cancer	0.00573	0.0125	CbGbCtD
Etravirine—CYP3A4—Mitoxantrone—prostate cancer	0.00544	0.0119	CbGbCtD
Etravirine—CYP3A4—Estradiol—prostate cancer	0.00525	0.0115	CbGbCtD
Etravirine—ABCB1—Docetaxel—prostate cancer	0.00524	0.0114	CbGbCtD
Etravirine—CYP3A4—Prednisone—prostate cancer	0.00452	0.00987	CbGbCtD
Etravirine—ABCB1—Doxorubicin—prostate cancer	0.00391	0.00853	CbGbCtD
Etravirine—CYP3A4—Etoposide—prostate cancer	0.00343	0.00749	CbGbCtD
Etravirine—CYP3A4—Docetaxel—prostate cancer	0.00314	0.00685	CbGbCtD
Etravirine—CYP3A4—Doxorubicin—prostate cancer	0.00234	0.00511	CbGbCtD
Etravirine—CYP2C19—urine—prostate cancer	0.0013	0.225	CbGeAlD
Etravirine—CYP2C9—urine—prostate cancer	0.00101	0.174	CbGeAlD
Etravirine—Rilpivirine—CYP2C19—prostate cancer	0.000974	0.611	CrCbGaD
Etravirine—ABCB4—testis—prostate cancer	0.000871	0.151	CbGeAlD
Etravirine—CYP3A4—urine—prostate cancer	0.000768	0.133	CbGeAlD
Etravirine—ABCB4—lymph node—prostate cancer	0.000631	0.109	CbGeAlD
Etravirine—Rilpivirine—CYP3A4—prostate cancer	0.000619	0.389	CrCbGaD
Etravirine—ABCB1—prostate gland—prostate cancer	0.000195	0.0338	CbGeAlD
Etravirine—CYP3A4—renal system—prostate cancer	0.000188	0.0325	CbGeAlD
Etravirine—ABCB1—seminal vesicle—prostate cancer	0.000165	0.0286	CbGeAlD
Etravirine—ABCB1—epithelium—prostate cancer	0.000143	0.0248	CbGeAlD
Etravirine—ABCB1—renal system—prostate cancer	0.000133	0.023	CbGeAlD
Etravirine—ABCB1—urethra—prostate cancer	0.000131	0.0226	CbGeAlD
Etravirine—ABCB1—bone marrow—prostate cancer	0.000101	0.0174	CbGeAlD
Etravirine—ABCB1—testis—prostate cancer	8.6e-05	0.0149	CbGeAlD
Etravirine—ABCB1—lymph node—prostate cancer	6.23e-05	0.0108	CbGeAlD
Etravirine—Constipation—Etoposide—prostate cancer	5.55e-05	0.000367	CcSEcCtD
Etravirine—Conjunctivitis—Epirubicin—prostate cancer	5.55e-05	0.000367	CcSEcCtD
Etravirine—Dizziness—Estradiol—prostate cancer	5.54e-05	0.000366	CcSEcCtD
Etravirine—Hypertension—Capecitabine—prostate cancer	5.53e-05	0.000366	CcSEcCtD
Etravirine—Dry mouth—Docetaxel—prostate cancer	5.5e-05	0.000364	CcSEcCtD
Etravirine—Confusional state—Docetaxel—prostate cancer	5.44e-05	0.00036	CcSEcCtD
Etravirine—Anxiety—Capecitabine—prostate cancer	5.43e-05	0.000359	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	5.41e-05	0.000358	CcSEcCtD
Etravirine—Hepatobiliary disease—Epirubicin—prostate cancer	5.4e-05	0.000357	CcSEcCtD
Etravirine—Discomfort—Capecitabine—prostate cancer	5.38e-05	0.000356	CcSEcCtD
Etravirine—Vision blurred—Prednisone—prostate cancer	5.37e-05	0.000355	CcSEcCtD
Etravirine—Infection—Docetaxel—prostate cancer	5.36e-05	0.000355	CcSEcCtD
Etravirine—Feeling abnormal—Etoposide—prostate cancer	5.35e-05	0.000354	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—prostate cancer	5.34e-05	0.000353	CcSEcCtD
Etravirine—Diarrhoea—Mitoxantrone—prostate cancer	5.34e-05	0.000353	CcSEcCtD
Etravirine—Dry mouth—Capecitabine—prostate cancer	5.33e-05	0.000352	CcSEcCtD
Etravirine—Vomiting—Estradiol—prostate cancer	5.33e-05	0.000352	CcSEcCtD
Etravirine—Gastrointestinal pain—Etoposide—prostate cancer	5.31e-05	0.000351	CcSEcCtD
Etravirine—Shock—Docetaxel—prostate cancer	5.31e-05	0.000351	CcSEcCtD
Etravirine—Nervous system disorder—Docetaxel—prostate cancer	5.29e-05	0.00035	CcSEcCtD
Etravirine—Ill-defined disorder—Prednisone—prostate cancer	5.29e-05	0.00035	CcSEcCtD
Etravirine—Thrombocytopenia—Docetaxel—prostate cancer	5.28e-05	0.000349	CcSEcCtD
Etravirine—Rash—Estradiol—prostate cancer	5.28e-05	0.000349	CcSEcCtD
Etravirine—Dermatitis—Estradiol—prostate cancer	5.28e-05	0.000349	CcSEcCtD
Etravirine—Anaemia—Prednisone—prostate cancer	5.27e-05	0.000349	CcSEcCtD
Etravirine—Confusional state—Capecitabine—prostate cancer	5.27e-05	0.000348	CcSEcCtD
Etravirine—Headache—Estradiol—prostate cancer	5.25e-05	0.000347	CcSEcCtD
Etravirine—Skin disorder—Docetaxel—prostate cancer	5.24e-05	0.000347	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	5.23e-05	0.000346	CcSEcCtD
Etravirine—Angioedema—Prednisone—prostate cancer	5.21e-05	0.000345	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—prostate cancer	5.19e-05	0.000343	CcSEcCtD
Etravirine—Infection—Capecitabine—prostate cancer	5.19e-05	0.000343	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—prostate cancer	5.17e-05	0.000342	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—prostate cancer	5.15e-05	0.00034	CcSEcCtD
Etravirine—Anorexia—Docetaxel—prostate cancer	5.14e-05	0.00034	CcSEcCtD
Etravirine—Malaise—Prednisone—prostate cancer	5.14e-05	0.00034	CcSEcCtD
Etravirine—Shock—Capecitabine—prostate cancer	5.14e-05	0.00034	CcSEcCtD
Etravirine—Body temperature increased—Etoposide—prostate cancer	5.13e-05	0.000339	CcSEcCtD
Etravirine—Abdominal pain—Etoposide—prostate cancer	5.13e-05	0.000339	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—prostate cancer	5.13e-05	0.000339	CcSEcCtD
Etravirine—Nervous system disorder—Capecitabine—prostate cancer	5.12e-05	0.000339	CcSEcCtD
Etravirine—Vertigo—Prednisone—prostate cancer	5.12e-05	0.000339	CcSEcCtD
Etravirine—Hepatitis—Epirubicin—prostate cancer	5.12e-05	0.000339	CcSEcCtD
Etravirine—Thrombocytopenia—Capecitabine—prostate cancer	5.11e-05	0.000338	CcSEcCtD
Etravirine—Syncope—Prednisone—prostate cancer	5.11e-05	0.000338	CcSEcCtD
Etravirine—Hypoaesthesia—Epirubicin—prostate cancer	5.1e-05	0.000337	CcSEcCtD
Etravirine—Skin disorder—Capecitabine—prostate cancer	5.07e-05	0.000336	CcSEcCtD
Etravirine—Urinary tract disorder—Epirubicin—prostate cancer	5.06e-05	0.000335	CcSEcCtD
Etravirine—Hyperhidrosis—Capecitabine—prostate cancer	5.05e-05	0.000334	CcSEcCtD
Etravirine—Connective tissue disorder—Epirubicin—prostate cancer	5.03e-05	0.000333	CcSEcCtD
Etravirine—Urethral disorder—Epirubicin—prostate cancer	5.02e-05	0.000332	CcSEcCtD
Etravirine—Loss of consciousness—Prednisone—prostate cancer	5.01e-05	0.000331	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—prostate cancer	4.99e-05	0.00033	CcSEcCtD
Etravirine—Anorexia—Capecitabine—prostate cancer	4.98e-05	0.000329	CcSEcCtD
Etravirine—Nausea—Estradiol—prostate cancer	4.97e-05	0.000329	CcSEcCtD
Etravirine—Vomiting—Mitoxantrone—prostate cancer	4.96e-05	0.000328	CcSEcCtD
Etravirine—Convulsion—Prednisone—prostate cancer	4.94e-05	0.000327	CcSEcCtD
Etravirine—Hypertension—Prednisone—prostate cancer	4.92e-05	0.000326	CcSEcCtD
Etravirine—Rash—Mitoxantrone—prostate cancer	4.92e-05	0.000326	CcSEcCtD
Etravirine—Dermatitis—Mitoxantrone—prostate cancer	4.92e-05	0.000325	CcSEcCtD
Etravirine—Headache—Mitoxantrone—prostate cancer	4.89e-05	0.000323	CcSEcCtD
Etravirine—Insomnia—Docetaxel—prostate cancer	4.88e-05	0.000323	CcSEcCtD
Etravirine—Paraesthesia—Docetaxel—prostate cancer	4.84e-05	0.00032	CcSEcCtD
Etravirine—Erythema multiforme—Epirubicin—prostate cancer	4.84e-05	0.00032	CcSEcCtD
Etravirine—Anxiety—Prednisone—prostate cancer	4.84e-05	0.00032	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.82e-05	0.000319	CcSEcCtD
Etravirine—Somnolence—Docetaxel—prostate cancer	4.8e-05	0.000317	CcSEcCtD
Etravirine—Discomfort—Prednisone—prostate cancer	4.79e-05	0.000317	CcSEcCtD
Etravirine—Eye disorder—Epirubicin—prostate cancer	4.79e-05	0.000317	CcSEcCtD
Etravirine—Hypersensitivity—Etoposide—prostate cancer	4.78e-05	0.000316	CcSEcCtD
Etravirine—Cardiac disorder—Epirubicin—prostate cancer	4.75e-05	0.000314	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—prostate cancer	4.74e-05	0.000313	CcSEcCtD
Etravirine—Insomnia—Capecitabine—prostate cancer	4.72e-05	0.000313	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—prostate cancer	4.72e-05	0.000312	CcSEcCtD
Etravirine—Paraesthesia—Capecitabine—prostate cancer	4.69e-05	0.00031	CcSEcCtD
Etravirine—Decreased appetite—Docetaxel—prostate cancer	4.69e-05	0.00031	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—prostate cancer	4.68e-05	0.00031	CcSEcCtD
Etravirine—Gastrointestinal disorder—Docetaxel—prostate cancer	4.66e-05	0.000308	CcSEcCtD
Etravirine—Asthenia—Etoposide—prostate cancer	4.66e-05	0.000308	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—prostate cancer	4.66e-05	0.000308	CcSEcCtD
Etravirine—Fatigue—Docetaxel—prostate cancer	4.65e-05	0.000308	CcSEcCtD
Etravirine—Angiopathy—Epirubicin—prostate cancer	4.65e-05	0.000307	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—prostate cancer	4.65e-05	0.000307	CcSEcCtD
Etravirine—Nausea—Mitoxantrone—prostate cancer	4.64e-05	0.000307	CcSEcCtD
Etravirine—Immune system disorder—Epirubicin—prostate cancer	4.63e-05	0.000306	CcSEcCtD
Etravirine—Infection—Prednisone—prostate cancer	4.62e-05	0.000306	CcSEcCtD
Etravirine—Mediastinal disorder—Epirubicin—prostate cancer	4.62e-05	0.000305	CcSEcCtD
Etravirine—Pain—Docetaxel—prostate cancer	4.61e-05	0.000305	CcSEcCtD
Etravirine—Constipation—Docetaxel—prostate cancer	4.61e-05	0.000305	CcSEcCtD
Etravirine—Shock—Prednisone—prostate cancer	4.58e-05	0.000303	CcSEcCtD
Etravirine—Nervous system disorder—Prednisone—prostate cancer	4.56e-05	0.000302	CcSEcCtD
Etravirine—Decreased appetite—Capecitabine—prostate cancer	4.54e-05	0.0003	CcSEcCtD
Etravirine—Skin disorder—Prednisone—prostate cancer	4.52e-05	0.000299	CcSEcCtD
Etravirine—Gastrointestinal disorder—Capecitabine—prostate cancer	4.51e-05	0.000298	CcSEcCtD
Etravirine—Fatigue—Capecitabine—prostate cancer	4.5e-05	0.000298	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisone—prostate cancer	4.5e-05	0.000298	CcSEcCtD
Etravirine—Mental disorder—Epirubicin—prostate cancer	4.49e-05	0.000297	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—prostate cancer	4.48e-05	0.000296	CcSEcCtD
Etravirine—Constipation—Capecitabine—prostate cancer	4.47e-05	0.000295	CcSEcCtD
Etravirine—Pain—Capecitabine—prostate cancer	4.47e-05	0.000295	CcSEcCtD
Etravirine—Malnutrition—Epirubicin—prostate cancer	4.46e-05	0.000295	CcSEcCtD
Etravirine—Feeling abnormal—Docetaxel—prostate cancer	4.45e-05	0.000294	CcSEcCtD
Etravirine—Diarrhoea—Etoposide—prostate cancer	4.44e-05	0.000294	CcSEcCtD
Etravirine—Anorexia—Prednisone—prostate cancer	4.43e-05	0.000293	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—prostate cancer	4.43e-05	0.000293	CcSEcCtD
Etravirine—Gastrointestinal pain—Docetaxel—prostate cancer	4.41e-05	0.000292	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—prostate cancer	4.4e-05	0.000291	CcSEcCtD
Etravirine—Flatulence—Epirubicin—prostate cancer	4.39e-05	0.000291	CcSEcCtD
Etravirine—Tension—Epirubicin—prostate cancer	4.37e-05	0.000289	CcSEcCtD
Etravirine—Nervousness—Epirubicin—prostate cancer	4.33e-05	0.000286	CcSEcCtD
Etravirine—Feeling abnormal—Capecitabine—prostate cancer	4.3e-05	0.000285	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—prostate cancer	4.3e-05	0.000284	CcSEcCtD
Etravirine—Dizziness—Etoposide—prostate cancer	4.29e-05	0.000284	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—prostate cancer	4.28e-05	0.000283	CcSEcCtD
Etravirine—Gastrointestinal pain—Capecitabine—prostate cancer	4.27e-05	0.000283	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—prostate cancer	4.27e-05	0.000283	CcSEcCtD
Etravirine—Abdominal pain—Docetaxel—prostate cancer	4.26e-05	0.000282	CcSEcCtD
Etravirine—Body temperature increased—Docetaxel—prostate cancer	4.26e-05	0.000282	CcSEcCtD
Etravirine—Insomnia—Prednisone—prostate cancer	4.21e-05	0.000278	CcSEcCtD
Etravirine—Vision blurred—Epirubicin—prostate cancer	4.2e-05	0.000278	CcSEcCtD
Etravirine—Paraesthesia—Prednisone—prostate cancer	4.18e-05	0.000276	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—prostate cancer	4.15e-05	0.000275	CcSEcCtD
Etravirine—Ill-defined disorder—Epirubicin—prostate cancer	4.14e-05	0.000274	CcSEcCtD
Etravirine—Abdominal pain—Capecitabine—prostate cancer	4.13e-05	0.000273	CcSEcCtD
Etravirine—Body temperature increased—Capecitabine—prostate cancer	4.13e-05	0.000273	CcSEcCtD
Etravirine—Vomiting—Etoposide—prostate cancer	4.13e-05	0.000273	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—prostate cancer	4.13e-05	0.000273	CcSEcCtD
Etravirine—Anaemia—Epirubicin—prostate cancer	4.12e-05	0.000273	CcSEcCtD
Etravirine—Rash—Etoposide—prostate cancer	4.09e-05	0.000271	CcSEcCtD
Etravirine—Dermatitis—Etoposide—prostate cancer	4.09e-05	0.000271	CcSEcCtD
Etravirine—Headache—Etoposide—prostate cancer	4.07e-05	0.000269	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—prostate cancer	4.06e-05	0.000269	CcSEcCtD
Etravirine—Tension—Doxorubicin—prostate cancer	4.05e-05	0.000268	CcSEcCtD
Etravirine—Decreased appetite—Prednisone—prostate cancer	4.04e-05	0.000268	CcSEcCtD
Etravirine—Malaise—Epirubicin—prostate cancer	4.02e-05	0.000266	CcSEcCtD
Etravirine—Fatigue—Prednisone—prostate cancer	4.01e-05	0.000265	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—prostate cancer	4.01e-05	0.000265	CcSEcCtD
Etravirine—Vertigo—Epirubicin—prostate cancer	4.01e-05	0.000265	CcSEcCtD
Etravirine—Syncope—Epirubicin—prostate cancer	4e-05	0.000264	CcSEcCtD
Etravirine—Constipation—Prednisone—prostate cancer	3.98e-05	0.000263	CcSEcCtD
Etravirine—Hypersensitivity—Docetaxel—prostate cancer	3.97e-05	0.000263	CcSEcCtD
Etravirine—Loss of consciousness—Epirubicin—prostate cancer	3.92e-05	0.000259	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—prostate cancer	3.89e-05	0.000257	CcSEcCtD
Etravirine—Asthenia—Docetaxel—prostate cancer	3.87e-05	0.000256	CcSEcCtD
Etravirine—Convulsion—Epirubicin—prostate cancer	3.86e-05	0.000256	CcSEcCtD
Etravirine—Nausea—Etoposide—prostate cancer	3.86e-05	0.000255	CcSEcCtD
Etravirine—Hypertension—Epirubicin—prostate cancer	3.85e-05	0.000255	CcSEcCtD
Etravirine—Hypersensitivity—Capecitabine—prostate cancer	3.85e-05	0.000255	CcSEcCtD
Etravirine—Feeling abnormal—Prednisone—prostate cancer	3.83e-05	0.000254	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—prostate cancer	3.83e-05	0.000253	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—prostate cancer	3.81e-05	0.000252	CcSEcCtD
Etravirine—Gastrointestinal pain—Prednisone—prostate cancer	3.8e-05	0.000252	CcSEcCtD
Etravirine—Anxiety—Epirubicin—prostate cancer	3.78e-05	0.00025	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.77e-05	0.000249	CcSEcCtD
Etravirine—Discomfort—Epirubicin—prostate cancer	3.75e-05	0.000248	CcSEcCtD
Etravirine—Asthenia—Capecitabine—prostate cancer	3.75e-05	0.000248	CcSEcCtD
Etravirine—Malaise—Doxorubicin—prostate cancer	3.72e-05	0.000246	CcSEcCtD
Etravirine—Dry mouth—Epirubicin—prostate cancer	3.71e-05	0.000246	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—prostate cancer	3.71e-05	0.000245	CcSEcCtD
Etravirine—Syncope—Doxorubicin—prostate cancer	3.7e-05	0.000245	CcSEcCtD
Etravirine—Diarrhoea—Docetaxel—prostate cancer	3.69e-05	0.000244	CcSEcCtD
Etravirine—Body temperature increased—Prednisone—prostate cancer	3.68e-05	0.000243	CcSEcCtD
Etravirine—Abdominal pain—Prednisone—prostate cancer	3.68e-05	0.000243	CcSEcCtD
Etravirine—Confusional state—Epirubicin—prostate cancer	3.67e-05	0.000243	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—prostate cancer	3.63e-05	0.00024	CcSEcCtD
Etravirine—Infection—Epirubicin—prostate cancer	3.61e-05	0.000239	CcSEcCtD
Etravirine—Shock—Epirubicin—prostate cancer	3.58e-05	0.000237	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—prostate cancer	3.57e-05	0.000236	CcSEcCtD
Etravirine—Diarrhoea—Capecitabine—prostate cancer	3.57e-05	0.000236	CcSEcCtD
Etravirine—Nervous system disorder—Epirubicin—prostate cancer	3.57e-05	0.000236	CcSEcCtD
Etravirine—Dizziness—Docetaxel—prostate cancer	3.57e-05	0.000236	CcSEcCtD
Etravirine—Thrombocytopenia—Epirubicin—prostate cancer	3.56e-05	0.000236	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—prostate cancer	3.56e-05	0.000236	CcSEcCtD
Etravirine—Skin disorder—Epirubicin—prostate cancer	3.53e-05	0.000234	CcSEcCtD
Etravirine—Hyperhidrosis—Epirubicin—prostate cancer	3.52e-05	0.000233	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—prostate cancer	3.5e-05	0.000232	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.49e-05	0.000231	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—prostate cancer	3.47e-05	0.00023	CcSEcCtD
Etravirine—Anorexia—Epirubicin—prostate cancer	3.47e-05	0.000229	CcSEcCtD
Etravirine—Dizziness—Capecitabine—prostate cancer	3.45e-05	0.000228	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—prostate cancer	3.43e-05	0.000227	CcSEcCtD
Etravirine—Vomiting—Docetaxel—prostate cancer	3.43e-05	0.000227	CcSEcCtD
Etravirine—Hypersensitivity—Prednisone—prostate cancer	3.43e-05	0.000227	CcSEcCtD
Etravirine—Rash—Docetaxel—prostate cancer	3.4e-05	0.000225	CcSEcCtD
Etravirine—Dermatitis—Docetaxel—prostate cancer	3.4e-05	0.000225	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—prostate cancer	3.39e-05	0.000225	CcSEcCtD
Etravirine—Headache—Docetaxel—prostate cancer	3.38e-05	0.000224	CcSEcCtD
Etravirine—Infection—Doxorubicin—prostate cancer	3.34e-05	0.000221	CcSEcCtD
Etravirine—Asthenia—Prednisone—prostate cancer	3.34e-05	0.000221	CcSEcCtD
Etravirine—Vomiting—Capecitabine—prostate cancer	3.32e-05	0.00022	CcSEcCtD
Etravirine—Shock—Doxorubicin—prostate cancer	3.31e-05	0.000219	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—prostate cancer	3.3e-05	0.000218	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—prostate cancer	3.3e-05	0.000218	CcSEcCtD
Etravirine—Rash—Capecitabine—prostate cancer	3.29e-05	0.000218	CcSEcCtD
Etravirine—Insomnia—Epirubicin—prostate cancer	3.29e-05	0.000218	CcSEcCtD
Etravirine—Dermatitis—Capecitabine—prostate cancer	3.29e-05	0.000218	CcSEcCtD
Etravirine—Headache—Capecitabine—prostate cancer	3.27e-05	0.000216	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—prostate cancer	3.27e-05	0.000216	CcSEcCtD
Etravirine—Paraesthesia—Epirubicin—prostate cancer	3.27e-05	0.000216	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—prostate cancer	3.25e-05	0.000215	CcSEcCtD
Etravirine—Somnolence—Epirubicin—prostate cancer	3.23e-05	0.000214	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—prostate cancer	3.21e-05	0.000212	CcSEcCtD
Etravirine—Nausea—Docetaxel—prostate cancer	3.2e-05	0.000212	CcSEcCtD
Etravirine—Diarrhoea—Prednisone—prostate cancer	3.18e-05	0.000211	CcSEcCtD
Etravirine—Decreased appetite—Epirubicin—prostate cancer	3.16e-05	0.000209	CcSEcCtD
Etravirine—Gastrointestinal disorder—Epirubicin—prostate cancer	3.14e-05	0.000208	CcSEcCtD
Etravirine—Fatigue—Epirubicin—prostate cancer	3.14e-05	0.000208	CcSEcCtD
Etravirine—Constipation—Epirubicin—prostate cancer	3.11e-05	0.000206	CcSEcCtD
Etravirine—Pain—Epirubicin—prostate cancer	3.11e-05	0.000206	CcSEcCtD
Etravirine—Nausea—Capecitabine—prostate cancer	3.1e-05	0.000205	CcSEcCtD
Etravirine—Dizziness—Prednisone—prostate cancer	3.08e-05	0.000204	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—prostate cancer	3.05e-05	0.000201	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—prostate cancer	3.02e-05	0.0002	CcSEcCtD
Etravirine—Feeling abnormal—Epirubicin—prostate cancer	3e-05	0.000198	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—prostate cancer	2.99e-05	0.000198	CcSEcCtD
Etravirine—Gastrointestinal pain—Epirubicin—prostate cancer	2.98e-05	0.000197	CcSEcCtD
Etravirine—Vomiting—Prednisone—prostate cancer	2.96e-05	0.000196	CcSEcCtD
Etravirine—Rash—Prednisone—prostate cancer	2.93e-05	0.000194	CcSEcCtD
Etravirine—Dermatitis—Prednisone—prostate cancer	2.93e-05	0.000194	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—prostate cancer	2.93e-05	0.000194	CcSEcCtD
Etravirine—Headache—Prednisone—prostate cancer	2.91e-05	0.000193	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.91e-05	0.000192	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—prostate cancer	2.9e-05	0.000192	CcSEcCtD
Etravirine—Pain—Doxorubicin—prostate cancer	2.88e-05	0.00019	CcSEcCtD
Etravirine—Constipation—Doxorubicin—prostate cancer	2.88e-05	0.00019	CcSEcCtD
Etravirine—Abdominal pain—Epirubicin—prostate cancer	2.88e-05	0.00019	CcSEcCtD
Etravirine—Body temperature increased—Epirubicin—prostate cancer	2.88e-05	0.00019	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—prostate cancer	2.77e-05	0.000184	CcSEcCtD
Etravirine—Nausea—Prednisone—prostate cancer	2.76e-05	0.000183	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.75e-05	0.000182	CcSEcCtD
Etravirine—Hypersensitivity—Epirubicin—prostate cancer	2.68e-05	0.000177	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—prostate cancer	2.66e-05	0.000176	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—prostate cancer	2.66e-05	0.000176	CcSEcCtD
Etravirine—Asthenia—Epirubicin—prostate cancer	2.61e-05	0.000173	CcSEcCtD
Etravirine—Diarrhoea—Epirubicin—prostate cancer	2.49e-05	0.000165	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—prostate cancer	2.48e-05	0.000164	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—prostate cancer	2.42e-05	0.00016	CcSEcCtD
Etravirine—Dizziness—Epirubicin—prostate cancer	2.41e-05	0.000159	CcSEcCtD
Etravirine—Vomiting—Epirubicin—prostate cancer	2.31e-05	0.000153	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—prostate cancer	2.3e-05	0.000152	CcSEcCtD
Etravirine—Rash—Epirubicin—prostate cancer	2.29e-05	0.000152	CcSEcCtD
Etravirine—Dermatitis—Epirubicin—prostate cancer	2.29e-05	0.000152	CcSEcCtD
Etravirine—Headache—Epirubicin—prostate cancer	2.28e-05	0.000151	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—prostate cancer	2.23e-05	0.000147	CcSEcCtD
Etravirine—Nausea—Epirubicin—prostate cancer	2.16e-05	0.000143	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—prostate cancer	2.14e-05	0.000142	CcSEcCtD
Etravirine—Rash—Doxorubicin—prostate cancer	2.12e-05	0.00014	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—prostate cancer	2.12e-05	0.00014	CcSEcCtD
Etravirine—Headache—Doxorubicin—prostate cancer	2.11e-05	0.00014	CcSEcCtD
Etravirine—Nausea—Doxorubicin—prostate cancer	2e-05	0.000132	CcSEcCtD
Etravirine—ABCB1—Metabolism—CYP2C18—prostate cancer	6.79e-06	7.85e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LRP2—prostate cancer	6.79e-06	7.85e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.77e-06	7.83e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HPGD—prostate cancer	6.77e-06	7.83e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTA1—prostate cancer	6.69e-06	7.74e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—P4HB—prostate cancer	6.65e-06	7.7e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC22A1—prostate cancer	6.63e-06	7.67e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HSD3B2—prostate cancer	6.61e-06	7.65e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTO1—prostate cancer	6.61e-06	7.65e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NAT2—prostate cancer	6.61e-06	7.65e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.56e-06	7.58e-05	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	6.52e-06	7.54e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC22A1—prostate cancer	6.47e-06	7.49e-05	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	6.47e-06	7.49e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SULT2A1—prostate cancer	6.46e-06	7.48e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	6.36e-06	7.36e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MED12—prostate cancer	6.36e-06	7.36e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.36e-06	7.35e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PLCB2—prostate cancer	6.34e-06	7.33e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LRP2—prostate cancer	6.34e-06	7.33e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2C18—prostate cancer	6.34e-06	7.33e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GNG5—prostate cancer	6.31e-06	7.3e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SULT2A1—prostate cancer	6.31e-06	7.3e-05	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	6.31e-06	7.3e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—P4HB—prostate cancer	6.22e-06	7.19e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MED12—prostate cancer	6.21e-06	7.18e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP7B1—prostate cancer	6.19e-06	7.16e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTAP—prostate cancer	6.19e-06	7.16e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GNG5—prostate cancer	6.16e-06	7.12e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOA3—prostate cancer	6.08e-06	7.03e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC22A1—prostate cancer	6.05e-06	7e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SULT1E1—prostate cancer	6.03e-06	6.98e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SRD5A1—prostate cancer	6.03e-06	6.98e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	5.98e-06	6.91e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.97e-06	6.91e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOA3—prostate cancer	5.93e-06	6.86e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SULT2A1—prostate cancer	5.89e-06	6.82e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MED12—prostate cancer	5.8e-06	6.71e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HPGDS—prostate cancer	5.8e-06	6.71e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.75e-06	6.66e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACSL4—prostate cancer	5.75e-06	6.66e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GNG5—prostate cancer	5.75e-06	6.65e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HPGDS—prostate cancer	5.66e-06	6.55e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ACHE—prostate cancer	5.62e-06	6.5e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—prostate cancer	5.62e-06	6.5e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2C19—prostate cancer	5.62e-06	6.5e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2A6—prostate cancer	5.56e-06	6.43e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOA3—prostate cancer	5.54e-06	6.41e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.54e-06	6.4e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UMPS—prostate cancer	5.52e-06	6.38e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PHGDH—prostate cancer	5.52e-06	6.38e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ARG2—prostate cancer	5.52e-06	6.38e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ACHE—prostate cancer	5.49e-06	6.35e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—prostate cancer	5.49e-06	6.35e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.44e-06	6.3e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2A6—prostate cancer	5.42e-06	6.28e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LDHB—prostate cancer	5.41e-06	6.26e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKR1C3—prostate cancer	5.41e-06	6.25e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PRKACB—prostate cancer	5.38e-06	6.22e-05	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	5.33e-06	6.16e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP17A1—prostate cancer	5.32e-06	6.16e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.31e-06	6.14e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HPGDS—prostate cancer	5.29e-06	6.11e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKR1C3—prostate cancer	5.28e-06	6.1e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2C19—prostate cancer	5.25e-06	6.08e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.25e-06	6.07e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PRKACB—prostate cancer	5.25e-06	6.07e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP17A1—prostate cancer	5.19e-06	6.01e-05	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.14e-06	5.94e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PDHA1—prostate cancer	5.13e-06	5.93e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UCP3—prostate cancer	5.13e-06	5.93e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TCN2—prostate cancer	5.13e-06	5.93e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA3—prostate cancer	5.13e-06	5.93e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—prostate cancer	5.13e-06	5.93e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ACHE—prostate cancer	5.13e-06	5.93e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOA2—prostate cancer	5.07e-06	5.87e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2A6—prostate cancer	5.07e-06	5.86e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.05e-06	5.84e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOA2—prostate cancer	4.95e-06	5.73e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKR1C3—prostate cancer	4.93e-06	5.7e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PRKACB—prostate cancer	4.9e-06	5.67e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.89e-06	5.66e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.89e-06	5.66e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP17A1—prostate cancer	4.85e-06	5.61e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC5A5—prostate cancer	4.84e-06	5.6e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.79e-06	5.54e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP2E1—prostate cancer	4.73e-06	5.47e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC5A5—prostate cancer	4.72e-06	5.46e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA4—prostate cancer	4.69e-06	5.43e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.69e-06	5.43e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NQO1—prostate cancer	4.67e-06	5.41e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOA2—prostate cancer	4.62e-06	5.35e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP2E1—prostate cancer	4.61e-06	5.34e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TH—prostate cancer	4.61e-06	5.33e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.58e-06	5.29e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA2—prostate cancer	4.57e-06	5.29e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NQO1—prostate cancer	4.56e-06	5.28e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP3A4—prostate cancer	4.56e-06	5.27e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.53e-06	5.24e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCG5—prostate cancer	4.52e-06	5.22e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.52e-06	5.22e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TH—prostate cancer	4.49e-06	5.2e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1B1—prostate cancer	4.48e-06	5.18e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP3A4—prostate cancer	4.45e-06	5.15e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC5A5—prostate cancer	4.41e-06	5.1e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTA1—prostate cancer	4.41e-06	5.1e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1B1—prostate cancer	4.37e-06	5.06e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTO1—prostate cancer	4.36e-06	5.04e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.36e-06	5.04e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NAT2—prostate cancer	4.36e-06	5.04e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GGT1—prostate cancer	4.34e-06	5.02e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP2E1—prostate cancer	4.31e-06	4.98e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOA1—prostate cancer	4.27e-06	4.94e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NQO1—prostate cancer	4.26e-06	4.93e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GGT1—prostate cancer	4.23e-06	4.9e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP19A1—prostate cancer	4.21e-06	4.87e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TH—prostate cancer	4.2e-06	4.86e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PLCB2—prostate cancer	4.18e-06	4.84e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.18e-06	4.84e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LRP2—prostate cancer	4.18e-06	4.84e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.17e-06	4.83e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOA1—prostate cancer	4.17e-06	4.83e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP3A4—prostate cancer	4.16e-06	4.81e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.13e-06	4.78e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP19A1—prostate cancer	4.11e-06	4.76e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—P4HB—prostate cancer	4.1e-06	4.74e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1B1—prostate cancer	4.08e-06	4.73e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—RXRA—prostate cancer	4.07e-06	4.7e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.99e-06	4.61e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—RXRA—prostate cancer	3.97e-06	4.59e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GGT1—prostate cancer	3.96e-06	4.58e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.95e-06	4.57e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—COMT—prostate cancer	3.92e-06	4.53e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—prostate cancer	3.9e-06	4.51e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOA1—prostate cancer	3.9e-06	4.51e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.89e-06	4.5e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.84e-06	4.44e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ITPR1—prostate cancer	3.83e-06	4.44e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MED12—prostate cancer	3.82e-06	4.42e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—COMT—prostate cancer	3.82e-06	4.42e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—prostate cancer	3.8e-06	4.4e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GNG5—prostate cancer	3.79e-06	4.39e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.77e-06	4.36e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ITPR1—prostate cancer	3.74e-06	4.33e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—RXRA—prostate cancer	3.71e-06	4.29e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOA3—prostate cancer	3.65e-06	4.23e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TYMS—prostate cancer	3.62e-06	4.19e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.61e-06	4.17e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—prostate cancer	3.58e-06	4.14e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—COMT—prostate cancer	3.57e-06	4.13e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—prostate cancer	3.55e-06	4.11e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TYMS—prostate cancer	3.54e-06	4.09e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—LPL—prostate cancer	3.52e-06	4.07e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ITPR1—prostate cancer	3.5e-06	4.05e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—prostate cancer	3.5e-06	4.04e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HPGDS—prostate cancer	3.49e-06	4.03e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.46e-06	4.01e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.44e-06	3.98e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—LPL—prostate cancer	3.43e-06	3.97e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1A1—prostate cancer	3.4e-06	3.93e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACHE—prostate cancer	3.38e-06	3.91e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—prostate cancer	3.38e-06	3.91e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ERCC2—prostate cancer	3.37e-06	3.9e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.34e-06	3.87e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1A1—prostate cancer	3.31e-06	3.83e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TYMS—prostate cancer	3.3e-06	3.82e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ERCC2—prostate cancer	3.29e-06	3.8e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—prostate cancer	3.27e-06	3.78e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.25e-06	3.76e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PRKACB—prostate cancer	3.23e-06	3.74e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—LPL—prostate cancer	3.21e-06	3.71e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.2e-06	3.7e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTHFR—prostate cancer	3.17e-06	3.66e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PPARA—prostate cancer	3.11e-06	3.59e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.1e-06	3.58e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTHFR—prostate cancer	3.09e-06	3.57e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ERCC2—prostate cancer	3.07e-06	3.55e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOA2—prostate cancer	3.05e-06	3.53e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PPARA—prostate cancer	3.03e-06	3.51e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CAV1—prostate cancer	2.92e-06	3.38e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.91e-06	3.37e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTHFR—prostate cancer	2.89e-06	3.34e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CAV1—prostate cancer	2.85e-06	3.3e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.84e-06	3.29e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PPARA—prostate cancer	2.83e-06	3.28e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NQO1—prostate cancer	2.81e-06	3.25e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.79e-06	3.23e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TH—prostate cancer	2.77e-06	3.2e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.69e-06	3.12e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CAV1—prostate cancer	2.66e-06	3.08e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CG—prostate cancer	2.66e-06	3.08e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GGT1—prostate cancer	2.61e-06	3.02e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CG—prostate cancer	2.6e-06	3e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOA1—prostate cancer	2.57e-06	2.97e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.54e-06	2.94e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.53e-06	2.93e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—INS—prostate cancer	2.52e-06	2.91e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CREBBP—prostate cancer	2.47e-06	2.85e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—INS—prostate cancer	2.46e-06	2.84e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—RXRA—prostate cancer	2.44e-06	2.83e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.42e-06	2.81e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CREBBP—prostate cancer	2.41e-06	2.78e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—COMT—prostate cancer	2.35e-06	2.72e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.34e-06	2.71e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.34e-06	2.7e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ITPR1—prostate cancer	2.31e-06	2.67e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—INS—prostate cancer	2.3e-06	2.66e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CD—prostate cancer	2.28e-06	2.64e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CREBBP—prostate cancer	2.25e-06	2.6e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NOS3—prostate cancer	2.21e-06	2.55e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TYMS—prostate cancer	2.18e-06	2.52e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NOS3—prostate cancer	2.15e-06	2.49e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.15e-06	2.49e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.13e-06	2.47e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—LPL—prostate cancer	2.11e-06	2.45e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.04e-06	2.36e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.04e-06	2.36e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ERCC2—prostate cancer	2.02e-06	2.34e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTGS2—prostate cancer	2.02e-06	2.34e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NOS3—prostate cancer	2.01e-06	2.33e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.99e-06	2.3e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTGS2—prostate cancer	1.97e-06	2.28e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.9e-06	2.2e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PPARA—prostate cancer	1.87e-06	2.16e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.86e-06	2.15e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.84e-06	2.13e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTEN—prostate cancer	1.76e-06	2.04e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CAV1—prostate cancer	1.76e-06	2.03e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTEN—prostate cancer	1.72e-06	1.99e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—EP300—prostate cancer	1.68e-06	1.94e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—EP300—prostate cancer	1.64e-06	1.9e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTEN—prostate cancer	1.61e-06	1.86e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.6e-06	1.85e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—EP300—prostate cancer	1.53e-06	1.77e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—INS—prostate cancer	1.51e-06	1.75e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.48e-06	1.72e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.41e-06	1.63e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NOS3—prostate cancer	1.33e-06	1.54e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.24e-06	1.44e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.23e-06	1.42e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—prostate cancer	1.21e-06	1.4e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.13e-06	1.31e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTEN—prostate cancer	1.06e-06	1.22e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—prostate cancer	1.01e-06	1.17e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—EP300—prostate cancer	1.01e-06	1.17e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—prostate cancer	9.9e-07	1.15e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—prostate cancer	9.25e-07	1.07e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.47e-07	8.64e-06	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—prostate cancer	6.1e-07	7.06e-06	CbGpPWpGaD
